Skip to main content

Peer Review reports

From: The role of Shenqi Fuzheng injection as adjuvant therapy for breast cancer: an overview of systematic reviews and meta-analyses

Original Submission
2 Feb 2023 Submitted Original manuscript
17 Feb 2023 Author responded Author comments - Li Hou
22 Feb 2023 Author responded Author comments - Li Hou
Resubmission - Version 2
17 Feb 2023 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
17 May 2023 Reviewed Reviewer Report
20 May 2023 Reviewed Reviewer Report - Arun Kumar
21 May 2023 Reviewed Reviewer Report - Nobendu Mukerjee
2 Jun 2023 Author responded Author comments - Li Hou
Resubmission - Version 4
2 Jun 2023 Submitted Manuscript version 4
4 Jun 2023 Author responded Author comments - Li Hou
Resubmission - Version 5
4 Jun 2023 Submitted Manuscript version 5
5 Jun 2023 Author responded Author comments - Li Hou
Resubmission - Version 6
5 Jun 2023 Submitted Manuscript version 6
6 Jun 2023 Author responded Author comments - Li Hou
Resubmission - Version 7
6 Jun 2023 Submitted Manuscript version 7
7 Jun 2023 Reviewed Reviewer Report - Nobendu Mukerjee
15 Jun 2023 Reviewed Reviewer Report
30 Jun 2023 Author responded Author comments - Li Hou
Resubmission - Version 8
30 Jun 2023 Submitted Manuscript version 8
1 Nov 2023 Author responded Author comments - Li Hou
Resubmission - Version 9
1 Nov 2023 Submitted Manuscript version 9
Publishing
22 Nov 2023 Editorially accepted
11 Jan 2024 Article published 10.1186/s12906-023-04274-4

You can find further information about peer review here.

Back to article page